Discontinued — last reported Q4 '21
An increase typically reflects recent acquisitions within the segment, while a decrease may indicate impairment charges due to underperformance or changes in market conditions. Significant goodwill balances suggest a strategy of growth through consolidation and the integration of external technologies.
This metric represents the carrying value of goodwill specifically allocated to the Healthcare and Life Sciences busines...
Peers in the medical device and life sciences sector often carry significant goodwill balances due to frequent M&A activity; investors compare this to segment-specific earnings to assess the return on invested capital from past acquisitions.
ste_segment_healthcare_life_sciences_goodwill| Q4 '21 | |
|---|---|
| Value | $1.34B |